Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role and function validation of P2RX4 as a novel cancer biomarker in pan-cancer analysis

3 Apr 2025

Abstract excerpt

Purinergic Receptor P2X4 (P2RX4) is implicated in the carcinogenesis of several cancers, but no extensive study on its role in different forms of cancer. Expression level, gene mutation, immune infiltration, pathway enrichment, and prognostic value analysis of P2RX4 were performed based on multiple publicly available databases such as TCGA, GTEx, GEO, TIMER2, cBioportal, and Metascape databases. Western blot and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40181033
DOI: 10.1038/s41598-025-95247-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role and function validation of P2RX4 as a novel cancer biomarker in pan-cancer analysisPMID 40181033Read ↗

Systematic Pan-Cancer Analysis Showed that P2RY13 was Associated with Immune Microenvironment and PrognosisSemantic proximity Read ↗

PRRX2 predicts poor survival prognosis, and promotes malignant phenotype of lung adenocarcinoma via transcriptional activates PSMD1Semantic proximity Read ↗

Pan-cancer analysis reveals the value of FDX1 as a novel biomarker in the prognosis and immunotherapy in human tumorsSemantic proximity Read ↗

P2RX7 functions as a putative biomarker of gastric cancer and contributes to worse prognosisSemantic proximity Read ↗

Screening and validation of plasma cell-derived, purinergic, and calcium signalling-related gene signatures to predict prognosis and PD- L1/PD-1 blockade responses in lung adenocarcinomaSemantic proximity Read ↗

Pan-Cancer Analysis of the Role of the Ferroptosis-Related Biomarker GPX4: A Potential Target for Prognosis and ImmunotherapySemantic proximity Read ↗

Systematic pan-cancer analysis reveals XCR1 as a Prognostic and Immunological BiomarkerSemantic proximity Read ↗

Bioinformatics analysis and experimental verification of NLRX1 as a prognostic factor for esophageal squamous cell carcinomaSemantic proximity Read ↗

An association between ATP7B expression and human cancer prognosis and immunotherapy: a pan-cancer perspectiveSemantic proximity Read ↗

Comprehensive pan-cancer analysis reveals clinical and immunological significance of ATP7A as a potential biomarker in hepatic carcinomaSemantic proximity Read ↗

Pre-clinical validation of a novel pan-cancer CAR-T cell immunotherapy against nfP2X7Semantic proximity Read ↗

A Pan-cancer Analysis of the Prognostic and Immunological Role of PPP1R14ASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.